Delivery Order SPE2DB22D3501-SPE2DB25FVM47
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,249.10 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,161.57 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with an ultimate completion date of October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a pharmaceutical delivery under DLA's medical supply chain operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as...
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,499.40 on November 14, 2025, for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitive award, which carries a firm fixed price structure and an ultimate completion date of November 17, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a $5,099.04 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supplies to support federal medical procurement needs. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for Humulin R 500 unit/mL KwikPen insulin pens (3mL). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 28, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $15,081.42 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $15,528.32 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This non-competitive delivery order carries a firm fixed price and is scheduled for completion by September 8, 2025. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, where the products will be supplied from. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVM47Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.76 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL) with an ultimate completion date of May 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement needs. The delivery order is placed under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. This delivery order reflects routine pharmaceutical procurement through DLA's established supply chain infrastructure to support military and veteran healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition, with the company consistently delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The award of this insulin product aligns with the company's established role as a key pharmaceutical prime vendor supporting the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 4/30/25 |